Summit Therapeutics Inc.

Historical 13F Holders

Symbol
SMMT
CUSIP
86627T108
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 259 103 M $2.13 B
2025 Q2 255 98.1 M $2.08 B
2025 Q1 235 98.0 M $1.89 B
2024 Q4 234 92.6 M $1.65 B
2024 Q3 198 84.6 M $1.85 B
2024 Q2 140 72.7 M $567 M
2024 Q1 116 51.3 M $213 M
2023 Q4 107 33.6 M $87.6 M
2023 Q3 101 32.3 M $60.5 M
2023 Q2 106 34.9 M $87.7 M
2023 Q1 102 21.1 M $37.0 M
2022 Q4 68 8.19 M $34.9 M
2022 Q3 46 3.18 M $3.78 M
2022 Q2 43 8.46 M $8.46 M
2022 Q1 51 11.0 M $27.8 M
2021 Q4 58 11.1 M $30.0 M
2021 Q3 56 11.0 M $55.3 M
2021 Q2 58 11.0 M $82.4 M
2021 Q1 41 9.29 M $54.5 M
2020 Q4 34 9.09 M $42.7 M
2020 Q3 17 7.75 M $26.8 M